Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy

Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy

Abstract Background Lysophosphatidic acid (LPA) and lysophosphatidylcholine (LPC) are bioactive lysophospholipids involved in the pathogenesis of renal diseases, especially the renal fibrosis. Plasma LPC concentrations in chronic kidney disease (CKD) patients are lower or similar to those observed i...

Full description

Bibliographic Details
Main Authors: Anna Michalczyk, Barbara Dołęgowska, Rafał Heryć, Dariusz Chlubek, Krzysztof Safranow
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Lipids in Health and Disease
Subjects:
Lysophosphatidic acid
LPA
Lysophosphatidylcholine
LPC
Lysophospholipids
Bioactive lipids
Online Access:http://link.springer.com/article/10.1186/s12944-019-1040-5

Internet

http://link.springer.com/article/10.1186/s12944-019-1040-5

Similar Items